company background image
3004

Guangzhou Wondfo BiotechLtd SZSE:300482 Stock Report

Last Price

CN¥29.33

Market Cap

CN¥13.0b

7D

3.3%

1Y

-31.8%

Updated

03 Oct, 2022

Data

Company Financials +
300482 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance5/6
Financial Health5/6
Dividends3/6

300482 Stock Overview

Guangzhou Wondfo Biotech Co.,Ltd, a biological company, engages in the research and development, production, and sale of point-of-care testing products, and rapid diagnosis and chronic disease management solutions.

Guangzhou Wondfo Biotech Co.,Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Guangzhou Wondfo BiotechLtd
Historical stock prices
Current Share PriceCN¥29.33
52 Week HighCN¥71.00
52 Week LowCN¥28.33
Beta0.17
1 Month Change-10.22%
3 Month Change-30.32%
1 Year Change-31.79%
3 Year Change-21.87%
5 Year Change-6.19%
Change since IPO495.77%

Recent News & Updates

Shareholder Returns

300482CN Medical EquipmentCN Market
7D3.3%11.7%-1.5%
1Y-31.8%-23.0%-19.2%

Return vs Industry: 300482 underperformed the CN Medical Equipment industry which returned -23% over the past year.

Return vs Market: 300482 underperformed the CN Market which returned -19.2% over the past year.

Price Volatility

Is 300482's price volatile compared to industry and market?
300482 volatility
300482 Average Weekly Movement4.5%
Medical Equipment Industry Average Movement5.9%
Market Average Movement5.8%
10% most volatile stocks in CN Market9.2%
10% least volatile stocks in CN Market3.8%

Stable Share Price: 300482 is less volatile than 75% of CN stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 300482's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19923,411Wen Mei Lihttps://www.wondfo.com.cn

Guangzhou Wondfo Biotech Co.,Ltd, a biological company, engages in the research and development, production, and sale of point-of-care testing products, and rapid diagnosis and chronic disease management solutions. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious, fertility, and sexually transmitted diseases, as well as immunofluorescence devices to detect cardiovascular diseases, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and other diseases. It also provides blood gas, optical coagulation, and dry chemistry analyzers.

Guangzhou Wondfo Biotech Co.,Ltd Fundamentals Summary

How do Guangzhou Wondfo BiotechLtd's earnings and revenue compare to its market cap?
300482 fundamental statistics
Market CapCN¥13.04b
Earnings (TTM)CN¥1.26b
Revenue (TTM)CN¥5.54b

10.4x

P/E Ratio

2.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
300482 income statement (TTM)
RevenueCN¥5.54b
Cost of RevenueCN¥2.57b
Gross ProfitCN¥2.97b
Other ExpensesCN¥1.71b
EarningsCN¥1.26b

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)2.83
Gross Margin53.62%
Net Profit Margin22.69%
Debt/Equity Ratio16.4%

How did 300482 perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

11%

Payout Ratio